These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34987908)

  • 41. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iloprost inhalation for the treatment of severe persistent pulmonary hypertension of the newborn, experience at QSNICH.
    Chotigeat U; Champrasert M; Khorana M; Sangtaweesin V; Kanjanapattanakul W
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S89-94. PubMed ID: 25391178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia.
    Lilyasari O; Subekti Y; Atika N; Dinarti LK; Putri S; Opitasari C; Anggraini AB; Bussabawalai T; Teerawattananon Y
    BMC Health Serv Res; 2019 Aug; 19(1):573. PubMed ID: 31412857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension.
    Li X; Li T
    Front Pharmacol; 2020; 11():400. PubMed ID: 32308623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan.
    Goissen C; Ghyselen L; Tourneux P; Krim G; Storme L; Bou P; Maingourd Y
    Eur J Pediatr; 2008 Apr; 167(4):437-40. PubMed ID: 17701214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent pulmonary hypertension of the newborn: experience in a single institution.
    Hsieh WS; Yang PH; Fu RH
    Acta Paediatr Taiwan; 2001; 42(2):94-100. PubMed ID: 11355072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.
    Clozel M; Hess P; Rey M; Iglarz M; Binkert C; Qiu C
    Exp Biol Med (Maywood); 2006 Jun; 231(6):967-73. PubMed ID: 16741032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome.
    Nakwan N; Jain S; Kumar K; Hosono S; Hammoud M; Elsayed YY; Ariff S; Hasan B; Khowaja W; Poon WB
    J Matern Fetal Neonatal Med; 2020 Jun; 33(12):2032-2037. PubMed ID: 30318951
    [No Abstract]   [Full Text] [Related]  

  • 49. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
    Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
    J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.
    Lakshminrusimha S; Konduri GG; Steinhorn RH
    J Perinatol; 2016 Jun; 36 Suppl 2():S12-9. PubMed ID: 27225960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prevalence and characteristics of persistent pulmonary hypertension of the newborn. A multicenter study. The Study Group of the Società Italiana di Cardiologia Pediatrica (SICP)].
    Favilli S; De Simone L; Pollini I; Bettuzzi MG; Cianfrini D; Crepaz R; Santillo V; Trevisanuto D; Vignati G; Manetti A
    G Ital Cardiol; 1998 Nov; 28(11):1247-52. PubMed ID: 9866802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.
    McLaughlin V; Channick RN; Ghofrani HA; Lemarié JC; Naeije R; Packer M; Souza R; Tapson VF; Tolson J; Al Hiti H; Meyer G; Hoeper MM
    Eur Respir J; 2015 Aug; 46(2):405-13. PubMed ID: 26113687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension.
    Paul GA; Gibbs JS; Boobis AR; Abbas A; Wilkins MR
    Br J Clin Pharmacol; 2005 Jul; 60(1):107-12. PubMed ID: 15963102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sildenafil as “first line therapy” in pulmonary persistent hypertension of the newborn?
    Nassi N; Daniotti M; Agostiniani S; Lombardi E; Favilli S; Donzelli GP
    J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():104-5. PubMed ID: 20836736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment.
    Grünig E; Ohnesorge J; Benjamin N; Burhenne J; Enderle Y; Egenlauf B; Fischer C; Harutyunova S; Huppertz A; Klose H; Haefeli WE
    Respiration; 2017; 94(1):26-37. PubMed ID: 28494463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of Beraprost Sodium Combined with Sildenafil and Its Effects on Vascular Endothelial Function and Inflammation in Patients Experiencing Left Heart Failure Complicated with Pulmonary Arterial Hypertension.
    Sun D; Yang W; Wang Z; Gao B
    Med Sci Monit; 2021 Feb; 27():e928413. PubMed ID: 33531453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn.
    Pedersen J; Hedegaard ER; Simonsen U; Krüger M; Infanger M; Grimm D
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):392-406. PubMed ID: 29855164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on sildenafil combined with inhalational nitric oxide therapy on the curative effects and serum levels of HIF-1α, ET-1, and calcium in neonatal pulmonary hypertension.
    Liu G; Wu HW; Li ZG
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4683-4690. PubMed ID: 30058708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An international survey on persistent pulmonary hypertension of the newborn: A need for an evidence-based management.
    Nakwan N; Chaiwiriyawong P
    J Neonatal Perinatal Med; 2016 Sep; 9(3):243-50. PubMed ID: 27589551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use.
    Radicioni M; Bruni A; Camerini P
    Eur J Pediatr; 2011 Aug; 170(8):1075-8. PubMed ID: 21380943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.